NCT05912660
Completed
Not Applicable
Health Status of Patients After Surgically Implanted Biological and TAVI: a Population-based Retrospective Analysis
ConditionsAortic Valve Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Aortic Valve Disease
- Sponsor
- Medical University of Vienna
- Enrollment
- 18882
- Primary Endpoint
- all-cause mortality
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The overall project aim is to study outcomes following aortic valve replacement with surgically implanted bioprostheses or TAVI by retrieving data from the main social security carriers in Austria for the years 2010-2020.
Investigators
Hendrik Jan Ankersmit
Univ. Prof. , MD, MBA
Medical University of Vienna
Eligibility Criteria
Inclusion Criteria
- •isolated aortic valve replacement in Austria (surgically implanted bioprostheses or TAVI)
Exclusion Criteria
- •below 65 years of age
- •coronary revascularization within 4 months before the index procedure
- •concomitant heart surgery
Outcomes
Primary Outcomes
all-cause mortality
Time Frame: 10 years
all cause mortality after aortic valve replacement
Secondary Outcomes
- stroke(10 years)
- heart failure(10 years)
- myocardial infaction(10 years)
- reoperation(10 years)
Similar Trials
Completed
Not Applicable
Health Status of Patients After Surgically Implanted Biological and Mechanical Aortic Valves: a Population-based Retrospective Analysis (2010-2018)Aortic Valve DiseaseNCT04900909Medical University of Vienna13,993
Completed
Not Applicable
Health Status of < 50 Year Old Patients After Surgically Implanted Biological and Mechanical Aortic Valves: a Population-based Retrospective Analysis (2010-2020)Aortic Valve DiseaseNCT05627973Medical University of Vienna991
Recruiting
Not Applicable
Functional and Quality of Life Improvement Following Transcatheter Heart Valve ImplantationTrans Catheter Aortic ValveAortic StenosisNCT02023060Sheba Medical Center100
Active, not recruiting
Not Applicable
ASAN Medical Center Aortic Valve Replacement RegistryAortic Valve StenosisNCT03298178Ho-Jin Kim900
Active, not recruiting
Not Applicable
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).Severe Aortic StenosisNCT01586910Medtronic Cardiovascular1,746